Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease

Gut microbial dysbiosis and altered metabonomics have been implicated in the pathogenesis of Crohn’s disease (CD). The aim of our study was to characterize the gut microbiome structure and metabolic activities in pediatric CD patients with different clinical outcomes after infliximab (IFX) therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizhong, Gao, Xuefeng, Zhang, Xinyue, Xiao, Fangfei, Hu, Hui, Li, Xiaolu, Dong, Fang, Sun, Mingming, Xiao, Yongmei, Ge, Ting, Li, Dan, Yu, Guangjun, Liu, Zhanju, Zhang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808429/
https://www.ncbi.nlm.nih.gov/pubmed/33430702
http://dx.doi.org/10.1080/19490976.2020.1865708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808429/
https://www.ncbi.nlm.nih.gov/pubmed/33430702
http://dx.doi.org/10.1080/19490976.2020.1865708

Ejemplares similares